Murine studies using polyethylene glycol-modified recombinant human interleukin 2 (PEG-IL-2): antitumor effects of PEG-IL2 alone and in combination with adoptive cellular transfer.
Year: 1991
Type: article
Source: PubMed
Authors: J C Yang, S L Schwarz, D M Perry-Lalley, S A Rosenberg
Institutions: National Cancer Institute, National Institutes of Health
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2337259064
